Compared to the control group, the percentages of CD31+ positive cells were dramatically decreased in the high-dose Sanguinarine group but were unaffected in the low-dose Sanguinarine or the DDP group (Figures 1D, S4A), indicating that high-dose Sanguinarine can restrain tumor growth and angiogenesis. Here, PECAM1 is linked to neoplasm.